-Advertisement-
  About AE   About NHM   Contact Us   Terms of Use   Copyright Info   Privacy Policy   Advertising Policies   Site Map
   
Custom Search of AE Site
spacer spacer

Anti-Sense Making Sense

By Sean Henahan, Access Excellence

San Diego, CA (5/14/98)- Antisense medical technology may be starting to make sense, as a new drug using the technology shows promise in treatment of a potentially blinding infection in HIV patients.

The sequence of a nucleotide chain that contains the information for protein synthesis is called the sense sequence. The nucleotide chain that is complementary to the sense sequence is called its antisense sequence. Antisense drugs recognize and bind to the nucleotide sense sequence of specific mRNA molecules, preventing the synthesis of unwanted proteins, destroying the sense molecules in the process.

Fomivirsen is the first drug in this class to make it into the clinic. It is an antisense oligonucleotide that binds to and  disrupts the decoding of a virus called cytomegalovirus, a member of the herpes family. CMV infection is common in advanced AIDS infection and can cause blindness. The new drug targets CMV genetic information specifically and does not interfere with the functioning of human DNA.

antisense making sense

Researchers reported favorable results in a large clinical trial with fomivirsen at the 11th conference of the International Society for Antiviral Research. Patients with CMV retinitis, a vision-threatening eye infection, showed significant delays in disease progression after a short course of therapy. These results are similar to those seen with current antiviral treatments for CMV retinitis. However, the new drug caused fewer side effects and was much easier to administer, reported investigators.

Several other antisense compounds are in clinical trials. These include agents for treatment of  Crohn's disease; renal transplant rejection; rheumatoid arthritis; ulcerative colitis; asthma and cancer.


Related information on the Internet
What is Antisense?
 HIV Insite
 CMV Backgrounder

What's News Index

Feedback


 
Today's Health and
BioScience News
Science Update Archives Factoids Newsmaker Interviews
Archive

 
Custom Search on the AE Site

 

-Advertisement-